first_imgThe Disco Biscuits closed their annual Camp Bisco on Saturday night with a whopping three sets. After the previous two nights of festival heaven, the electronic jam band pioneers led their faithful followers through the most anticipated part of the weekend with several hours of improvised jamming within the compounds of their favorited compositions.Camp Bisco Program Guide Reveals New Disco Biscuits DatesThe first set opened with “Caves of the East” into “Loose Change.” From there, “Bernstein & Chasnoff” sandwiched an inverted version of “Highwire” and “Tempest” within a monstrous extended jam. The band closed the first set with “Mulberry’s Dream.”In true Disco Biscuits fashion, the second set opened and closed with “Morph Dusseldorf,” with a non-stop run of songs including an inverted version of “Above the Waves,” “The Champions,” and “Exodus” featuring first and only special guest, guitarist Tom Hamilton–who celebrated his 15th year in a row as a musician at Camp Bisco. “Above the Waves” reappeared before the enormous second set closed with “Morph Dusseldorf.”The Disco Biscuits Launch Free Emoji App, And It’s IncredibleThe band again appeared for a third set, beginning with “Dub Dribble” and “Helicopters,” a favorited song that again emerged to close the show. Donna Summer‘s “I Feel Love” was debuted, then followed by “Tricycle” and “Air Song.”The Disco Biscuits offered a free stream of their performances throughout the weekend, so you can enjoy all three sets below: Setlist: The Disco Biscuits | Camp Bisco | Montage Mountain, PA | 7/15/17I: Caves of the East-> Loose Change, Bernstein & Chasnoff-> Highwire (inverted)-> Tempest-> Bernstein & Chasnoff, Mulberry’s DreamII: Morph Dusseldorf-> Above the Waves (inverted)-> The Champions-> Exodus (w/ Tom Hamilton)-> Above the Waves-> Morph DusseldorfIII: Dub Dribble-> Helicopters-> I Feel Love (Donna Summer, 1st time played)-> Tricycle-> Air Song-> Helicopters[photo by Dave Vann]last_img

Related Posts

first_imgDeclaring the University’s efforts toimprove the state of global health knowledge, education, and capacity building to be one of her “very highestpriorities” as president of Harvard, Drew Faust today announced theappointment of Sue J. Goldie, Roger Irving Lee Professor of Public Health and director of the Center for Health DecisionScience at the Harvard School of Public Health, as the director of theHarvard Institute for Global Health (HIGH).Faust also announced that the workof HIGH is so integral to the long-term focus and goals of Harvard that theorganization that began its existence as an experimental faculty “initiative”has been granted permanent institute status.“I believe that this is truly a moment of specialpossibility for global health, both in the world and here at Harvard,” saidFaust. “If we needed to be reminded of this, we have been this past year, firstwith the global H1N1 pandemic, and then when the earthquake struck Haiti and wesaw the world come together.“We need to engage and equip our students, who aretelling us in ever increasing numbers that they want to engage in the globalhealth effort,” Faust continued. “We need to support the very best researchersand the work of our outstanding faculty, in fields stretching across thespectrum of inquiry from immunology to epidemiology, health policy, history,molecular biology, and philosophy. I have every confidence that Sue Goldie, whohas already demonstrated her outstanding scholarship, leadership, andcollaborative skills, is the person to lead this special effort.”The appointment ofGoldie, a MacArthur Foundation “genius award” recipient, marks the end of ayearlong, international search for a new director for HIGH. Goldie has beeninvolved with HIGH since 2007, and as co-director of the executive committeeworked to bring faculty from all parts of the University together, consistentlyadvocating on behalf of junior faculty interested in global health.Because HIGH isabove all a collaborative organization dedicated to educating and training thenext generation of global healthleaders, Faust also appointed two faculty leaders to direct thecritically important educational and training efforts.Paul Farmer, the Maude and LillianPresley Professor of Global Health and Social Medicine at Harvard MedicalSchool (HMS), will oversee global health medical education and physiciantraining. Farmer, who is also a MacArthur Fellowship winner, is chair of the Department ofGlobal Health and Social Medicine at HMS, a professor in the Department ofGlobal Health and Population at the Harvard School of Public Health,Chief of the Division ofGlobal Health Equity at Brigham and Women’s Hospital,and isperhaps best known internationally as the co-founder of Partners In Health,the global nonprofit health care delivery organization.David Cutler, the Otto EcksteinProfessor of Applied Economics in Harvard’s Department of Economics and amember of the faculty of the Harvard Kennedy School, will direct undergraduateand graduate programs in global health. Cutler, who worked on health carereform in the Clinton administration and served as a health care adviser to theObama campaign, is a member of HIGH’s faculty executive committee, served asHIGH’s interim director for the past year, and led the effort to create a secondaryconcentration in global health at Harvard College.Goldie said, “Strong leadership inglobal health already resides in the faculty of the Medical School, School ofPublic Health, and academic hospitals. As the faculty director for the HarvardInstitute for Global Health, I see myself principally as a coordinator,facilitator, and collaborator. With a leadership team comprised of myself, PaulFarmer, and David Cutler, I am confident we can create a University-wide community that is bound by a sense of sharedmission.”“Global health is an intellectual and practicaltopic of tremendous interest to our undergraduate and graduate students,”said Michael D. Smith, dean of the Faculty of Arts and Sciences and JohnH. Finley Jr. Professor of Engineering and Applied Sciences. “Professors Goldie,Farmer, and Cutler are exactly the kind of seasoned leaders we need for such animportant, University-wide institute. I am also thrilled that each bringsto the institute a deep commitment to Harvard’s extensive educational offeringsin global health.”Harvard Provost Steven E. Hymansaid that granting institute status to HIGH and appointing Goldie “mark a verysignificant step along what has been a 15-year journey toward a trulycollaborative and more interdisciplinary Harvard. Global health is an area inwhich we already have world-class researchers, clinicians, teachers, andstudents,” Hyman said. “By bringing them all together as parts of a coordinatedwhole, without boundaries or silos, we expect to have far more impact than wewould expect from the already considerable sum of the many parts of our globalhealth effort.”“It is my convictionthat for Harvard to remain a leader in the burgeoningfield of global health, we must invest heavily in linking service to trainingand research,” Farmer said. “Since global health is not a discipline, butrather a collection of problems, we need to draw on the strengths of themedical school, the school of public health and the teaching hospitals—andespecially on the work of our partner sites—to help tackle the biggestchallenge of our time: understanding and improving delivery of services in thiscountry and in others. Global health is a new paradigm and very different fromits predecessor paradigm, international health. Boston is on the globe,too,” Farmer noted.Cutler said he sees HIGHcoordinating the teaching and training of students at all levels. “Forundergraduates, this means having courses for those who want to learn a little,up to those who want to make global health their life’s focus,” he said. “Italso means providing students with the ability to interact with the world andpractice what they learn. For graduate students, this involves direct trainingin global health issues, access to people and research sites, and integrationof the skills of many different disciplines. It will take a collaboration offaculty all across Harvard to make this happen. I know the faculty are eager toparticipate, and I look forward to helping organize them.”The global health leadershipappointments were praised by both Julio Frenk, dean of the Harvard School ofPublic Health, and Jeffrey Flier, dean of Harvard Medical School.“SueGoldie, Paul Farmer, and David Cutler are uniquely qualified to lead HIGH to anew stage of development,” Frenk said.  “The key to achieving successfullythe Institute’s mission will continue to be the ability to build bridges acrossthe amazing intellectual capital of the entire university. Professors Goldie,Farmer, and Cutler have exceptional skills in team building and mentoring.They are also deeply committed to the educational mission of HIGH, asdemonstrated by their crucial role in expanding the course offerings in globalhealth and by their own dedication to teaching.”Flier said, “This is a signalmoment in our effort to bring together under a single banner the disparateparts of a world-class program in global health. I have no doubt that SueGoldie, Paul Farmer, and David Cutler have the vision, collaborative instincts,and determination to bring people together in this common cause, and thattogether they will create a truly collaborative, interdisciplinary program thatwill benefit not only all the world’s peoples, but also will benefit Harvard asa university.”Trained as a physician, decision scientist, and public healthresearcher, Goldie has broad interests that include using evidence-based policyto narrow the gap between rich and poor, leveraging science and technology astools for global diplomacy, strengthening capacity through sustainablenon-exploitative partnerships, and fostering innovation in education locally andglobally. Drawn to health problems in the mostvulnerable populations, she conducts rigorous analysis using themethods and tools of decision science, which uses mathematics to solve resourceproblems, to inform complex and difficult policy decisions. Her analytic work relates to awide range of topics — from vaccine-preventable diseases to maternal mortality— in many settings, from disparities in the United States to broad failures ofpublic health delivery in the poorest countries.An accomplishedscientist, Goldie has published 150 original research papers and hasbeen principal investigator on awards from the National Institutes of Health, theCenters for Disease Control, the Bill and Melinda Gates Foundation, the DorisDuke Foundation, and the MacArthur Foundation, which in 2005awarded her its grant “for genius and creativity” in applying the tools ofdecision science to combat major public health problems.She has received numerous teachingand mentorship awards, including the Harvard School of Public Health mentoringaward and the Everett Mendelsohn Excellence in Mentoring Award from HarvardUniversity. She serves on the StandingCommittee on Health Policy, teaches one of the largest classes at theSchool of Public Health in decision science, and this year also taught a newundergraduate class as part of the Gen Ed curriculum.A member of the Institute ofMedicine, Goldie is a graduate ofUnion College and Albany Medical College. She completed her internship andresidency in internal medicine at Yale New Haven Hospital, Yale UniversitySchool of Medicine, and earned her M.P.H. from the Harvard School of PublicHealth in 1997. She joined the faculty of the School of Public Health in 1998.last_img

first_imgDerek Mueller sang and acted his way through four years at Harvard, and now, with Commencement looming, he’s taking his show on the road.Mueller, a senior psychology concentrator and Mather House resident, spent the past three years as a member of the Hasty Pudding Theatricals, the nation’s oldest collegiate theatrical troupe, known for its annual burlesque show and for its traditional roasts of a Man and Woman of the Year, selected from the ranks of the world’s top entertainers.For the past year, Mueller served as Hasty Pudding’s cast vice president, helping guide the creative process that led to this year’s production, “Commie Dearest,” a heartfelt tale (not really) about a young girl (a man) in the 1950s suburbs, joining forces with communists to fight misogyny and win the American Dream. Mueller played “Olive Lucy,” the owner of the local bowling alley (what could be more American?) where the townspeople congregated.With work on next year’s production beginning in the spring, Mueller said Hasty Pudding dominated his time at Harvard, though he also spent his freshman year with the Krokodiloes, Harvard’s oldest a cappella singing group. Mueller said the Krokodiloes’ extensive summer tour allowed him to see countries on six continents.The Hasty Pudding Theatricals experience is so consuming that each spring when the year’s performance — which includes a spring break tour to New York and Bermuda — is over, Mueller said he finds himself at loose ends.“After the show ends and I get back from Bermuda, I don’t know what to do with my time. I wander about like a lost puppy,” Mueller said.Of course this year, with graduation looming, Mueller has a bit more to contemplate. When asked his plans, Mueller said without hesitation, “I want to be a pop singer.” He plans to embrace the vagaries of fame, fortune, and the entertainment industry and head west after graduation to Los Angeles, where he’ll work the phones and Internet and see what happens.After describing his plan, Mueller, who hails from Cincinnati, hastens to say that he’s not normally as impulsive as the plan sounds, but that it’s time for him to make this kind of a move and it’s one he’s excited about.Mueller has been interested in music since he was young. On arriving at Harvard, he decided not to pursue a music degree because it is focused on theory and he is more interested in performance. Psychology allows him to understand people better, which helps in acting. In addition to his time with the Krokodiloes and Hasty Pudding Theatricals, Mueller composed, sang, and played piano on his own. He acknowledges that the Hasty Pudding’s style is different from his own music, but he relishes the Pudding experience nonetheless.When asked what advice he’d give incoming freshmen, Mueller advises them not to listen to any.“Make your own mistakes,” Mueller said. “Trying to apply what others learned from their mistakes will short-circuit your own experience.”last_img

first_imgDeath rates from malaria have fallen significantly over the last decade, but plenty of work remains, with hundreds of thousands of children still dying from the disease every year, experts said Wednesday in a discussion at Harvard Kennedy School.The Harvard Malaria Forum gathered experts from the corporate and nonprofit sectors as well as academia to explore business approaches toward the goal of eliminating malaria deaths in the world.Panelists discussed companies’ efforts to fight malaria among employees, manufacture bed nets, distribute nets along supply chains, and alert government officials, concerned about foreign exchange, to the impact the ailment has on workers.International efforts over the last decade have paid off, reducing the malaria mortality rate from more than a million a year — where it stood for decades — to less than 700,000. Further, in places where malaria control measures are in place, mortality in children from all causes has fallen by half, panelists said, a reflection of the effect malaria has weakening children it doesn’t kill.The event was co-sponsored by a long list of organizations, including HKS’s Mossavar-Rahmani Center for Business and Government and the Harvard Global Health Institute. It featured panelists and participants from Harvard, the United Nations, ExxonMobil Foundation, McKinsey & Company, Sumitomo Chemical America, and Reservoir Capital Group.The world has stood in a similar place before, with an effective insecticide, DDT, and a new treatment drug, chloroquine, only to squander the gains, said Dyann Wirth (right), director of the Harvard Malaria Initiative. Also on the panel was Suzanne McCarron (left), president of the ExxonMobil Foundation.Ray Chambers, the U.N. Secretary-General’s Special Envoy for Malaria, updated a packed room at the Taubman Building on progress against the disease. More than $6 billion has been raised to fight the ailment and some 800 million people have been provided with insecticide-impregnated bed nets. Efforts have focused on nets as a relatively inexpensive intervention — malaria-carrying mosquitoes are active at night —as well as on providing medicine and indoor insecticidal spraying. It will take another $3.5 billion to achieve the goal of zero malaria deaths by 2015, Chambers said.Chambers counted as a victory the increased awareness of malaria as a global issue, saying that more than 50 percent of the American public views the disease as a problem, compared with just 21 percent six years ago.“We really need you and your cutting-edge ideas, because I think we’ve only scratched the surface of what can happen,” he told the audience.Panelists from the business community highlighted actions by companies working in malaria-endemic areas. Suzanne McCarron, president of the ExxonMobil Foundation, said the company started a $100 million anti-malaria program. ExxonMobil can’t replace government action, but it does share its experiences of malaria’s economic impact with government leaders, she said.Chambers said he believed the effort may soon transition from one driven by international donors to one increasingly driven by local demand. He believes that families will soon begin to buy bed nets on their own, convinced of their effectiveness. African leaders recently met to discuss how to continue efforts in their own countries, through taxes on airline tickets, financial transactions, and natural resources. With African economies beginning to grow, Chambers expects dependence on international donors to lessen over the next decade.Naohiro Takahashi, president of Sumitomo Chemical America, described the company’s development of a bed net factory in Tanzania, which began as part of Sumitomo’s desire to give back to those in need. The factory now produces about 30 percent of the world’s bed nets, employing 7,000 people to make 30 million nets each year.Though progress against the disease so far is encouraging, panelists warned about the danger of complacency. The world has stood in a similar place before, with an effective insecticide, DDT, and a new treatment drug, chloroquine, only to squander the gains, said Dyann Wirth, Strong Professor of Infectious Diseases at the Harvard School of Public Health and director of the Harvard Malaria Initiative.Drug resistance is a concern, Wirth said. A drug-resistant form of the malaria parasite has emerged in Southeast Asia, though it has so far not made the jump to Africa. Still, she said, a malaria-carrying mosquito can bite multiple people, and a single case can lead to as many as 100 secondary cases, meaning the disease can spread rapidly if neglected. Gains need to be solidified or outbreaks can erase progress. That means continued research into new drugs and insecticides is critical, Wirth said.“This is a potentially explosive disease,” Wirth said.last_img

Leave a Reply

Your email address will not be published. Required fields are marked *